JNCCN 360 - Non-Melanoma Skin Cancers

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Danny Rischin, MD, on Cutaneous Squamous Cell Carcinoma: Follow-up Data on Cemiplimab

Francis P. Worden, MD, on Vismodegib: Organ Preservation for Orbital/Periocular Basal Cell Carcinoma

Nikolaos Andreatos, MD, on Adverse Events Following Radiotherapy and Immunotherapy in Patients With Melanoma and Merkel Cell Carcinoma

Recent

KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma

Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies

Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna

Sun Health Behaviors and Skin Cancer Risk in Children: Public Health Report From Ireland

Published

Medical Literature

Cisplatin Electrochemotherapy for Small Non‐Melanoma Skin Lesions

Antimalaria Drug May Inhibit Virus-Positive Merkel Cell Carcinoma Growth

Multidisciplinary Approaches to Managing Merkel Cell Carcinoma

Skin Cancer Prevention: ASCO Issues Policy Statement

Ongoing

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

Available

Clinical Trials

University of Wisconsin Carbone Cancer Center

Memorial Sloan Kettering Cancer Center

Seidman Cancer Center

University of California San Diego Moores Cancer Center

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.